Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| 2'-C-Methyluridine | 2'-C-Methyluridine. Group: Biochemicals. Alternative Names: 1,3-bis(N-cyclohexyl)guanidine; 1-(2-C-Methyl- β-D-ribofuranosyl)uracil. Grades: Highly Purified. CAS No. 31448-54-1. Pack Sizes: 25mg. Molecular Formula: C10H14N2O6, Molecular Weight: 258.23. US Biological Life Sciences. |  Worldwide |
| 2'-C-Methyluridine | A2'-C-Me branched C-nucleoside that shows HCV polymerase inhibitory activity. Synonyms: 2'-C-Methyl-1-β-D-ribofuranosyluracil; 1-((2R,3R,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; 2'-Methyl Uridine; 1,3-bis(N-cyclohexyl)guanidine; 1-(2-C-Methyl-β-D-ribofuranosyl)uracil; 2,4(1H,3H)-pyrimidinedione, 1-(2-C-methyl-β-D-ribofuranosyl)-. Grades: ≥95%. CAS No. 31448-54-1. Molecular formula: C10H14N2O6. Mole weight: 258.23. |  |
| 2'-C-Methyluridine-5'-phosphoramidate Triethylamine Salt | 2'-C-Methyluridine-5'-phosphoramidate (TEA Salt) is the analog of 2'-C-Methyluridine, A 2'-C-Me branched C-nucleoside that shows HCV polymerase inhibitory activity. Synonyms: 1,3-bis(N-cyclohexyl)guanine Salt. Molecular formula: C18H36N4O8P. Mole weight: 467.47. | |
| 2'-C-Methyluridine-5'-phosphoramidate Triethylamine Salt | 2'-C-Methyluridine-5'-phosphoramidate Triethylamine Salt. Group: Biochemicals. Alternative Names: 1,3-bis(N-cyclohexyl)guanine Salt. Grades: Highly Purified. Pack Sizes: 10mg. Molecular Formula: C18H36N4O8P, Molecular Weight: 467.47. US Biological Life Sciences. | Worldwide |
| 2'-C-Methyluridine 5'-triphosphate lithium salt | 2'-C-Methyluridine 5'-triphosphate lithium salt is an indispensable chemical compound extensively applied in the biomedical field, serves as a pivotal constituent facilitating the fabrication of nucleoside analogs aimed for research a multitude of ailments, encompassing viral infections and malignancies. This stunning creation orchestrates a momentous function in the advancement of antiviral and anticancer pharmaceuticals, thereby equipping scientists with an invaluable asset to meticulously scrutinize and effectively counter these formidable afflictions. Molecular formula: C10H13N2O15P3Li4. Mole weight: 521.90. | |
| 2',3',5'-Tri-O-benzoyl-2'-C-methyluridine | 2',3',5'-Tri-O-benzoyl-2'-C-methyluridine is a meticulously constructed synthetic nucleoside analogue, having applications in the antiviral drug development. Synonyms: 1-(2,3,5-Tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)uracil; 2'-C-Methyl-2',3',5'-tri-O-benzoyluridine; (2R,3R,4R,5R)-5-((benzoyloxy)methyl)-2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3-methyltetrahydrofuran-3,4-diyl dibenzoate. Grades: ≥95%. CAS No. 23643-36-9. Molecular formula: C31H26N2O9. Mole weight: 570.55. | |
| 2',3',5'-Tri-O-benzoyl-5-hydroxymethyl-2'-C-methyluridine | 2',3',5'-Tri-O-benzoyl-5-hydroxymethyl-2'-C-methyluridine is a nucleoside derivative used in the synthesis of RNA molecules. It has potential applications in the treatment of viral infections such as HIV and hepatitis C, as well as in cancer therapy due to its ability to inhibit tumor growth. Synonyms: 2',3',5'-Tri-O-benzoyl-5-hydroxymethyl-2'-β-C-methyluridine. Grades: ≥95%. CAS No. 2305416-16-2. Molecular formula: C32H28N2O10. Mole weight: 600.57. | |
| 2'-Deoxy-2'-fluoro-2'-C-methyluridine 5'-triphosphate sodium salt | PSI-7409 tetrasodium is an active 5'-triphosphate metabolite of sofosbuvir (PSI-7977), inhibiting HCV NS5B polymerases, with IC50s of 1.6, 2.8, 0.7 and 2.6 μM for GT 1b_Con1, GT 2a_JFH1, GT 3a, and GT 4a NS5B polymerases, respectively. Synonyms: PSI-7409 (tetrasodium);tetrasodium; [[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate. Grades: ≥98% (HPLC). CAS No. 1621884-22-7. Molecular formula: C10H12FN2Na4O14P3. Mole weight: 588.09. | |
| 2'-Deoxy-5'-O-DMT-3'-C-methyluridine | 2'-Deoxy-5'-O-DMT-3'-C-methyluridine, being an essential compound in the field of biomedicine, finds widespread application due to its unique characteristics. It serves as a fundamental constituent in the synthesis of medicinal drugs, particularly those designed to combat viral infections and specific malignancies. | |
| 2'-O-Acetyl-5'-O-benzoyl-3'-deoxy-3'-C-methyluridine | 2'-O-Acetyl-5'-O-benzoyl-3'-deoxy-3'-C-methyluridine is a powerful nucleoside analogue that has garnered much attention in the field of drug development. Boasting remarkable antiviral and anticancer qualities, its mechanism of action is shrouded in scientific mystery. Renowned for inhibiting the growth of notorious viruses such as HIV and hepatitis C, 2'-O-Acetyl-5'-O-benzoyl-3'-deoxy-3'-C-methyluridine has been known to leave cancer cells trembling in its wake. With cell replication coming to an abrupt and permanent halt in the presence of this synthetic compound, it remains a highly sought-after substance in various research endeavors. Molecular formula: C19H20N2O7. Mole weight: 388.37. | |
| (2'R)-2'-deoxy-2'-fluoro-2'-C-methyluridine | PSI-6206 is a selective HCV RNA polymerase inhibitor. It is the unphosphorylated parent compound of triphosphate analog PSI-7409, which is a potent inhibitor of the HCV NS5B RNA dependent RNA polymerase. Synonyms: RO-2433; RO 2433; RO2433; PSI6206; PSI 6206; PSI-6206; GS331007; GS-331007; GS 331007; 2'-Deoxy-2'-fluoro-2'-C-methyluridine; Sofosbuvir Metabolite GS331007; 1-((2R,3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione. Grades: ≥95%. CAS No. 863329-66-2. Molecular formula: C10H13FN2O5. Mole weight: 260.22. | |
| 5-Hydroxymethyl-2'-C-methyluridine | 5-Hydroxymethyl-2'-C-methyluridine is a remarkable compound,functioning as an esteemed nucleoside analogue. It adeptly curtails viral replication while propelling disarray within the tumor cell proliferation. Synonyms: 5-Hydroxymethyl-2'-β-C-methyluridine; 1-[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]-5-(hydroxymethyl)pyrimidine-2,4-dione. Grades: ≥95%. CAS No. 2305415-92-1. Molecular formula: C11H16N2O7. Mole weight: 288.25. | |
| 5-Iodo-2'-C-methyluridine | 5-Iodo-2'-C-methyluridine, renowned for its extraordinary biomedical capabilities, offering an innovative solution in research of viral infections. By impeding viral RNA research and development, this compound effectively hinders viral replication and subsequent dissemination. Synonyms: 5-Iodo-2'-C-methyl-1-β-D-ribofuranosyluracil; 1-((2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)-5-iodopyrimidine-2,4(1H,3H)-dione; 5-Iodo-2'-β-C-methyluridine. Grades: ≥95%. CAS No. 1203461-96-4. Molecular formula: C10H13IN2O6. Mole weight: 384.12. | |
| 1- β-D-Arabinofuranosyluracil-2-C-methyl | 1- β-D-Arabinofuranosyluracil-2-C-methyl is an impurity of PSI-7977 (P839640), a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro- β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled PSI-7977 as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase. Group: Biochemicals. Grades: Highly Purified. CAS No. 114262-49-6. Pack Sizes: 25mg, 250mg. Molecular Formula: C10H14N2O6, Molecular Weight: 258.23. US Biological Life Sciences. | Worldwide |
| 1- β-D-Arabinofuranosyluracil-2-C-methyl-d3, 13C | 1- β-D-Arabinofuranosyluracil-2-C-methyl-d3, 13C is the labeled analogue of 1- β-D-Arabinofuranosyluracil-2-C-methyl (A764005), an impurity of PSI-7977 (P839640), a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro- β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled PSI-7977 as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase. Group: Biochemicals. Grades: Highly Purified. CAS No. 1256490-38-6. Pack Sizes: 2.5mg, 75mg. Molecular Formula: C913CH11D3N2O6, Molecular Weight: 262.24. US Biological Life Sciences. | Worldwide |
| 2',3',5'-Tri-O-benzoyl-2'-C-methyl-5-methyluridine | 2',3',5'-Tri-O-benzoyl-2'-C-methyl-5-methyluridine is a valuable compound in the biomedical industry. It finds applications in the development of antiviral drugs targeting diseases caused by RNA viruses, like hepatitis C and influenza. This compound's unique chemical structure contributes to its potential therapeutic properties, making it a promising candidate for drug discovery and research in the field of biomedicine. Synonyms: (2R,3R,4R,5R)-5-((benzoyloxy)methyl)-3-methyl-2-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl dibenzoate; 5-Methyl-2'-C-methyluridine 2',3',5'-tribenzoate; 2',3',5'-Tri-O-benzoyl-2'-β-C-methyl-5-methyluridine; 2',3',5'-Tri-O-benzoyl-5-methyl-2'-C-methyluridine. Grades: ≥95%. CAS No. 957535-53-4. Molecular formula: C32H28N2O9. Mole weight: 584.57. | |
| 2'-C-methyl-5-fluorouridine | 2'-C-methyl-5-fluorouridine, a modified nucleoside, is a compound that has generated substantial interest in the realm of cancer research due to its impressive performance against liver, breast, pancreatic, and colon cancer cells. Considered a promising therapeutic option, the compound's antitumor activity has been rigorously tested and documented, offering a potential solution to some of the deadliest cancers. Synonyms: 2'-β-C-methyl-5-fluorouridine; 1-((2R,3R,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)-5-fluoropyrimidine-2,4(1H,3H)-dione; 5-Fluoro-2'-C-methyluridine. Grades: ≥95%. CAS No. 23643-38-1. Molecular formula: C10H13FN2O6. Mole weight: 276.22. | |
| 2'-epi-Sofosbuvir Desphosphate | 2'-epi-Sofosbuvir Desphosphate is a possible metabolite of Sofosbuvir which is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Molecular formula: C10H13FN2O5. Mole weight: 260.22. | |
| 2-epi-Sofosbuvir Desphosphate | 2-epi-Sofosbuvir Desphosphate is possible metabolite of Sofosbuvir (P839640) which is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro- β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg. Molecular Formula: C10H13FN2O5, Molecular Weight: 260.22. US Biological Life Sciences. | Worldwide |
| (2'R)?-2'-?Deoxy-?2'-?fluoro-?2'-?methyl-uridine 5'-?Triphosphate Triethylammonium Salt | (2'R)?-2'-?Deoxy-?2'-?fluoro-?2'-?methyl-uridine 5'-?Triphosphate Tetrasodium Salt is an impurity of Sofosbuvir (P839640) which is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro- β-C-methyluridine-5'-monophosphate. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg, 10mg. Molecular Formula: C28H61FN5O14P3. US Biological Life Sciences. | Worldwide |
| (2'R)?-2'-?Deoxy-?2'-?fluoro-?2'-?methyl-uridine 5'-?Triphosphate Triethylammonium Salt | (2'R)?-2'-Deoxy-2'-fluoro-2'-methyl-uridine 5'-Triphosphate Tetrasodium Salt is an impurity of Sofosbuvir. That prodrug could be metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate. Synonyms: Sofosbuvir Impurity; RO 2433 Triphosphate Triethylammonium Salt. Grades: 95%. Molecular formula: C28H61FN5O14P3. Mole weight: 803.73. | |
| (2'R) -2'-Deoxy-3', 5'-bis-O-[ (1, 1-dimethylethyl) dimethylsilyl]-2'-fluoro-2'-methyl-uridine | (2'R) -2'-Deoxy-3', 5'-bis-O-[ (1, 1-dimethylethyl) dimethylsilyl]-2'-fluoro-2'-methyl-uridine is an intermediate in the synthesis of Sofosbuvir (R)-Phosphate (S675615), which is an impurity of PSI-7977 (P839640), a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro- β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled PSI-7977 as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase. Group: Biochemicals. Grades: Highly Purified. CAS No. 1393526-40-3. Pack Sizes: 10mg, 25mg. Molecular Formula: C22H41FN2O5Si2. US Biological Life Sciences. | Worldwide |
| (2'R) -2'-Deoxy-3'-O-[ (1, 1-dimethylethyl) dimethylsilyl]-2'-fluoro-2'-methyl-uridine | (2'R) -2'-Deoxy-3'-O-[ (1, 1-dimethylethyl) dimethylsilyl]-2'-fluoro-2'-methyl-uridine is an intermediate in the synthesis of Sofosbuvir (R)-Phosphate (S675615), which is an impurity of PSI-7977 (P839640), a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro- β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled PSI-7977 as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase. Group: Biochemicals. Grades: Highly Purified. CAS No. 1244762-86-4. Pack Sizes: 5mg, 10mg. Molecular Formula: C16H27FN2O5Si. US Biological Life Sciences. | Worldwide |
| 3'-b-C-Methyluridine | 3'-b-C-Methyluridine, a compound highly regarded in the biomedical sector, showcases immense significance due to its broad applications. It manifests exceptional potential in combating various diseases, including cancer, viral infections, and autoimmune disorders. Notably, it possesses pharmacological attributes as an antineoplastic agent, effectively hindering viral replication and orchestrating the modulation of immune responses. The utilization of 3'-b-C-Methyluridine in drug development and comprehensive biomedicine investigations exhibits considerable promise, highlighting its paramount importance in scientific research. Synonyms: 3'-beta-C-Methyluridine; 1-(3-C-methyl-β-D-ribofuranosyl)uracil; 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-hydroxymethyl-4-methyl-tetrahydro-furan-2-yl)-1H-pyrimidine-2,4-dione; 3'-C-methyluridine; 3'-methyluridine. Grades: ≥95%. CAS No. 80541-15-7. Molecular formula: C10H14N2O6. Mole weight: 258.23. | |
| 3'-beta-C-Methyl-5-methyluridine | 3'-beta-C-Methyl-5-methyluridine is a biomedicine used for the treatment of certain viral infections and as an antiviral drug. It works by interfering with the replication process of the virus and inhibiting its growth. Synonyms: 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-4-methyloxolan-2-yl]-5-methylpyrimidine-2,4-dione; Uridine, 5-methyl-3'-C-methyl-; 3'-β-C-Methyl-5-methyluridine; 5-Methyl-3'-C-methyluridine. Grades: ≥95%. CAS No. 934002-35-4. Molecular formula: C11H16N2O6. Mole weight: 272.25. | |
| 3-Deaza-4'-C-methyluridine | 3-Deaza-4'-C-methyluridine is an antiviral compound in the biomedical industry used for the research of viral infections such as hepatitis C and HIV. Synonyms: 4-Hydroxy-1-b-D-(4-C-methylribofuranosyl)-2(1H)-pyridinone. Grades: ≥95%. CAS No. 2305415-96-5. Molecular formula: C11H15NO6. Mole weight: 257.24. | |
| 3'-Deoxy-3'-C-methyluridine | 3'-Deoxy-3'-C-methyluridine. Group: Biochemicals. Grades: Highly Purified. CAS No. 444020-64-8. Pack Sizes: 1g, 2g, 5g, 10g. Molecular Formula: C10H14N2O5. US Biological Life Sciences. | Worldwide |
| 3'-Deoxy-3'-C-methyluridine | It is used for nucleoside and nucleic acid modifications. Synonyms: 3'-Deoxy-3'-alpha-C-methyluridine; 3'-Deoxy-3'-methyluridine; 3'-Methyl-3'-deoxyuridine; 1-((2R,3R,4S,5S)-3-Hydroxy-5-(hydroxymethyl)-4-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione. Grades: ≥95%. CAS No. 444020-64-8. Molecular formula: C10H14N2O5. Mole weight: 242.23. | |
| 3'-O-Benzyl Sofosbuvir Desphosphate | 3'-O-Benzyl Sofosbuvir Desphosphate may be a metabolite of Sofosbuvir, a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled PSI-7977 as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase. Synonyms: 1-((2R,3R,4R,5R)-4-(Benzyloxy)-3-fluoro-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione. Molecular formula: C17H19FN2O5. Mole weight: 350.34. | |
| 4-Deoxy-3'-beta-C-methyluridine | 4-Deoxy-3'-beta-C-methyluridine, a pivotal compound extensively utilized in the biomedical sector across multifarious applications, assumes a paramount role in the advancement of antiviral therapeutics, predominantly against RNA viruses like HIV and hepatitis C. Synonyms: 4-Deoxy-3'-β-C-methyluridine. Grades: ≥95%. CAS No. 1106013-87-9. Molecular formula: C10H14N2O5. Mole weight: 242.23. | |
| 5-Fluoro-3'-beta-C-methyluridine | 5-Fluoro-3'-beta-C-methyluridine is an immensely powerful antiviral entity, exhibiting inhibitory efficacy against select RNA viruses, notably hepatitis C virus and Zika virus. Focusing on its modus operandi, it exerts its effects by markedly impeding theenhancement and replication of viral RNA. Synonyms: 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-4-methyloxolan-2-yl]-5-fluoropyrimidine-2,4-dione; 5-Fluoro-3'-C-methyluridine. Grades: ≥95%. Molecular formula: C10H13FN2O6. Mole weight: 276.22. | |
| 5-Fluoro-4'-C-methyluridine | 5-Fluoro-4'-C-methyluridine is a pivotal chemical compound widely employed in the biomedical sector, showcasing remarkable antiviral attributes. It is tailored for research of viral infections. Synonyms: Uridine, 5-fluoro-4'-C-methyl-; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-5-methyloxolan-2-yl]-5-fluoropyrimidine-2,4-dione; 1-[5-Deoxy-4-(hydroxymethyl)-α-L-lyxofuranosyl]-5-fluoro-2,4(1H,3H)-pyrimidinedione. Grades: ≥95%. CAS No. 660845-69-2. Molecular formula: C10H13FN2O6. Mole weight: 276.22. | |
| 5-Methoxy-5'(R)-C-methyluridine | 5-Methoxy-5'(R)-C-methyluridine, a remarkable biomedicine, stands as a formidable force in combating viral infections, specifically those orchestrated by RNA viruses. Grades: ≥95%. Molecular formula: C11H16N2O7. Mole weight: 288.25. | |
| 5'O-Benzyl Sofosbuvir Desphosphate | 5'O-Benzyl Sofosbuvir Desphosphate is a possible metabolite of Sofosbuvir which is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Synonyms: 5'-O-Benzyl RO 2433. Molecular formula: C17H19FN2O5. Mole weight: 350.34. | |
| 5'(R)-C-Methyluridine | 5'(R)-C-Methyluridine is an essential biomedical compound, serving as an indispensable weapon in research of viral infections and cancer. Its remarkable antiviral properties enable the effective suppression of RNA-based viruses such as hepatitis and HIV. Moreover, by actively participating in the intricate process of RNA and DNA research and development, this compound greatly aids in unraveling the complexities of genetic diseases. Synonyms: 1-(6-Deoxy-b-D-allofuranosyl)-2,4(1H,3H)pyrimidinedione; 1-[(2R,3R,4S,5R)-3,4-Dihydroxy-5-((R)-1-hydroxy-ethyl)-tetrahydro-furan-2-yl]-1H-pyrimidine-2,4-dione; 1-(6-deoxy-β-D-allofuranosyl)uracil; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]pyrimidine-2,4-dione. Grades: ≥95%. CAS No. 72159-54-7. Molecular formula: C10H14N2O6. Mole weight: 258.23. | |
| α-Sofosbuvir Desphosphate | As a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate, α-Sofosbuvir Desphosphate is a possible metabolite of Sofosbuvir is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Molecular formula: C10H13FN2O5. Mole weight: 260.22. | |
| Chloro Sofosbuvir | Chloro Sofosbuvir is an impurity of Sofosbuvir; a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled Sofosbuvir as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase. Synonyms: N-[[P(S),2'R]-2'-Chloro-2'-deoxy-2'-methyl-P-phenyl-5'-uridylyl]-L-alanine 1-Methylethyl Ester. Grades: ≥98% (HPLC). CAS No. 1496552-51-2. Molecular formula: C22H29ClN3O9P. Mole weight: 545.91. | |
| ent-Sofosbuvir Desphosphate | ent-Sofosbuvir Desphosphate is a possible metabolite of prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Molecular formula: C10H13FN2O5. Mole weight: 260.22. | |
| N4,3',5'-Tribenzoyl,2'-deoxy-2'β-fluoro-2'C-α-methyl Cytidine | N4,3',5'-Tribenzoyl,2'-deoxy-2'β-fluoro-2'C-α-methyl Cytidine is an impurity of Sofosbuvir, a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate, is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled Sofosbuvir as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase. Synonyms: (2R,3R,4S,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl Benzoate. Molecular formula: C31H26FN3O7. Mole weight: 571.55. | |
| PSI 352707 Ammonium Salt | As a metabolite of PSI-7977, PSI 352707 Ammonium Salt is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Synonyms: (2S)-2- ( ( ( ( (2R, 3R, 4R, 5R)-5- (2, 4-Dioxo-3, 4-dihydropyrimidin-1 (2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy) (hydroxy)phosphoryl)amino)propanoic Acid Ammonium Salt; O-Desisopropyl O-Desphenyl Sofosbuvir Ammonium Salt. Grades: 90%. Molecular formula: C13H19FN3O9P.xNH3. Mole weight: 411.28. | |
| Sofosbuvir | Sofosbuvir is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled sofosbuvir as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase. Uses: Antiviral agents. Synonyms: PSI-7977; PSI 7977; PSI7977; GS7977; GS-7977; GS 7977; Sovaldi; N-[[P(S),2'R]-2'-deoxy-2'-fluoro-2'-methyl-P-phenyl-5'-uridylyl]-L-alanine, 1-methylethyl ester; Hepcinat; Hepcvir; Resof; SoviHep. Grades: >98%. CAS No. 1190307-88-0. Molecular formula: C22H29FN3O9P. Mole weight: 529.45. | |
| Sofosbuvir 3',5'-Bis-(S)-phosphate | Sofosbuvir 3',5'-Bis-(S)-phosphate, an impurity of PSI-7977, which is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled PSI-7977 as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase. Synonyms: (2S)-Isopropyl 2- ( ( ( ( (2R, 3R, 4R, 5R)-5- (2, 4-Dioxo-3, 4-dihydropyrimidin-1 (2H)-yl)-4-fluoro-2- ( ( ( (R)- ( ( (S)-1-isopropoxy-1-oxopropan-2-yl)amino) (phenoxy)phosphoryl)oxy)methyl)-4-methyltetrahydrofuran-3-yl)oxy) (phenoxy)phosphoryl)amino)propanoate. Grades: 98.77%. CAS No. 1337482-17-3. Molecular formula: C34H45FN4O13P2. Mole weight: 798.69. | |
| Sofosbuvir α-Isomer | As a derivative compound of Sofosbuvir, Sofosbuvir α-Isomer is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have shown PSI-7977 as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase. Synonyms: (S)-Isopropyl 2- ( ( (S)- ( ( (2R, 3R, 4R, 5S)-5- (2, 4-dioxo-3, 4-dihydropyrimidin-1 (2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy) (phenoxy)phosphoryl)amino)propanoate. Molecular formula: C22H29FN3O9P. Mole weight: 529.45. | |
| Sofosbuvir Carboxylic Acid | As an impurity of Sofosbuvir, Sofosbuvir Carboxylic Acid is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled Sofosbuvir as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase. Synonyms: (S)-2- ( ( (S)- ( ( (2R, 3R, 4R, 5R)-5- (2, 4-Dioxo-3, 4-dihydropyrimidin-1 (2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy) (phenoxy)phosphoryl)amino)propanoic Acid. Molecular formula: C19H23FN3O9P. Mole weight: 487.37. | |
| Sofosbuvir (PSI-7977, GS-7977) | PSI-7977 is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro- β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled PSI-7977 as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase. Group: Biochemicals. Alternative Names: Isopropyl (2S) -2- [ [ [ (2R, 3R, 4R, 5R) -5- (2, 4-dioxopyrimidin-1-yl) -4-fluoro-3-hydroxy-4-methyl-tetrahydrofuran-2-yl] methoxy-phenoxy-phosphoryl] amino] propanoate; N-[[P(S),2'R]-2'-deoxy-2'-fluoro-2'-methyl-P-phenyl-5'-uridylyl]-1-methylethyl Ester L-Alanine; GS-7977; PSI-7977. Grades: Highly Purified. CAS No. 1190307-88-0. Pack Sizes: 25mg, 50mg, 100mg, 250mg. Molecular Formula: C22H29FN3O9P, Molecular Weight: 529.45. US Biological Life Sciences. | Worldwide |
| 2',3',5'-Tri-O-benzoyl-5-hydroxymethyl-2'C-methyluridine | 2',3',5'-Tri-O-benzoyl-5-hydroxymethyl-2'C-methyluridine, an extensively employed compound within the biomedicine sector, exhibits great promise for the advancement of antiviral medications, particularly for the management of hepatitis C and other viral afflictions. Its extraordinary chemical composition enhances its effectiveness as an antiviral agent, thereby positioning it as a prospective subject necessitating additional investigation and development in the combat against viral ailments. | |
Our database is helping our users find suppliers everyday.
